Your R&D is world-class.
Let’s make your market entry equally brilliant.

Fractional operations, development, and regulatory support for biotechs expanding into Asia and researchers commercializing their technology.

You’ve spent years perfecting the science. But the path from the lab bench to the Asian market—and from research to a commercial product—is fraught with operational hurdles. Finding the right manufacturing partner, navigating HSA/SFDA regulations, or simply opening a legal entity can derail even the most promising technology. You don't need a full-time COO yet; you need a dedicated partner who has done it before.

The Exima way

We aren't just consultants; we are your fractional operational team. We embed ourselves in your vision. Based in Singapore, we work as an extension of your team to execute critical path activities. Behind every engagement is a collective of seasoned professionals—giving you depth, perspective, and a network that scales with your needs.

Services

Practical, senior-level support across the entire commercialization journey.

🌏

Asia Market Entry

  • Singapore company registration
  • Physical office setup & local representation
  • Partner identification & due diligence
  • Distributor / licensee scouting
🔬

Product Development & CMC

  • R&D to manufacturable product
  • Preclinical / clinical project management
  • Tech transfer & manufacturing oversight
  • Supply chain coordination
📋

Regulatory Affairs

  • HSA (Singapore) & ASEAN strategy
  • Clinical Trial Application (CTA) preparation
  • Market authorization submissions
  • Labeling / post-approval support
📈

Commercial Strategy & BD

  • Business development support
  • Investor / partner pitch decks
  • Commercialization roadmap
  • Technology out-licensing collateral

About Exima Bio

We are a team of seasoned biotech operators who have sat on both sides of the table—as R&D founders trying to commercialize, and as operational leads scaling into new territories. Our collective experience spans multinational pharma, agile startups, and Asian market entry. We come together to offer you a holistic safety net, ensuring no detail is missed.

Operational spine

From entity setup to finance and back-office—we build the infrastructure so you can focus on the science.

Product & regulatory core

CMC strategy, regulatory submissions, and bridging the gap between lab discovery and regulator acceptance.

Singapore: your gateway to Asia

Operating out of Singapore provides world‑class infrastructure, IP protection, and a regulatory framework (HSA) trusted globally. It is the ideal launchpad for clinical trials and market access across Southeast Asia and beyond.

Ready to accelerate your path to the Asian market?

Let's discuss how our partnership model can support your specific technology.

hello@eximabio.com

Or connect with us on LinkedIn